Actinium Pharmaceuticals Inc. | Key People and Executives
Sandesh Seth
Executive Chairman & Chief Executive Officer
Ajit S. Shetty
Independent Director
C. David Nicholson
Lead Independent Director
Jeffrey W. Chell
Independent Director
Richard I. Steinhart
Independent Director
Sandesh Seth
Executive Chairman & Chief Executive Officer
Steve Oloughlin
Principal Financial & Accounting Officer
Robert N. Daly
Vice President & Head-Clinical Operations
Dale L. Ludwig
Chief Scientific Officer
Mark S. Berger
Chief Medical Officer
Anil Kapur
Chief Commercial Officer
Nitya G. Ray
Executive Vice President
Maria Gomes Nunes
Manager-Quality Control & Assurance
Jeannine Larrieux
Director-Analytical Development
Laura Chen
Senior Quality Assurance Specialist
David Gould
Senior VP-Finance & Corporate Development
Rowena Choudrie
Director-Pharmaceutical Product Development
Richard M. Stone
Chief of Staff & Program Director
Ajit S. Shetty
Independent Director
C. David Nicholson
Lead Independent Director
Jeffrey W. Chell
Independent Director
Richard I. Steinhart
Independent Director
| Address |
275 Madison Avenue
New York New York 10016
United States
|
|
Employees
|
- |
| Website |
http://www.actiniumpharmaceuticals.com |
| Updated |
07/08/2019 |
| Actinium Pharmaceuticals, Inc. engages in the development of targeted therapies for patients with cancers lacking effective treatment options. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. |
